top of page
ABOUT US
CASE STUDIES
CASE STUDY 2
Objective:
A start-up pharmaceutical company, based in Switzerland, required competitive intelligence and product forecasting support for potential in-licensing of a late-stage development product for treatment of Lupus.
Project Delivery:
​
​
A product sales forecast was delivered to the client based on disease prevalence, target product profile, price benchmarking, and expected market share. This analysis was used by the client to propose a term sheet to the developer.
A comprehensive therapeutic area, pipeline and commercial sales review was performed on the indication to provide an understanding of epidemiology, burden of disease on patients and payors, current
treatments, unmet needs and the competitiveness of the target product in the context of other available products and development projects.
​
Objective:
A pharmaceutical client was interested in evaluating the Schizophrenia market, in order to make a strategic decision of whether to enter the European market with their own portfolio of anti-psychotics and leverage upon their proprietary long-acting injectables technology.
Project Delivery:
A full analysis of the competitive landscape was conducted to identify the number of patients affected by this heterogenous disorder, current treatments, unmet needs, major pharmaceutical players, and well as the direction of the market for oral and injectable anti-psychotic drugs.
The assessment revealed that despite a high unmet need for drugs with better tolerability and efficacy, the cost and risk of constructing a portfolio in Europe would be prohibitively high relative to the client’s investment profile. This knowledge allowed the company to make a well-informed strategic decision to out-licence their technology instead.
CASE STUDY 3
CASE STUDY 1
Objective:
A multinational pharmaceutical company with greater than
USD 2 billion global sales was seeking to expand its commercial footprint in Europe through acquisition of company with speciality prescription drugs sold predominantly via a retail channel.
They were interested particularly in the field of Women’s Health, CNS and respiratory disorders, and required that the acquisition target had established sales in at least one major European country.
Project Delivery:
A systematic search was performed on all biopharmaceutical
companies with reported European sales within the limits set by the client. Company sales were segmented by country, therapeutic class and distribution channel allowing the shortlisting of companies which had significant sales of products in at least one of the preferred therapeutic areas.
For shortlisted targets, a deeper analysis was conducted on their background, strategy and performance as well as a full portfolio review to assess the competitive status of their product portfolio.
EXPERTISE
SERVICES
ABOUT
The project resulted in identification of 16 companies which fulfilled therapeutic area and sales criteria in at least one major European country, and 4 additional companies with relevant sales across multiple European markets.
bottom of page